1. Home
  2. Analysis
  3. Stavudine
  4. Hypercalcaemia-aggravated

Stavudine and Hypercalcaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia aggravated is reported as a side effect among people who take Stavudine (stavudine), especially for people who are male, 40-49 old, also take Lamivudine, and have Hiv infection.

The phase IV clinical study analyzes which people have Hypercalcaemia aggravated when taking Stavudine. It is created by eHealthMe based on reports of 10,313 people who have side effects when taking Stavudine from the FDA, and is updated regularly.

What is Stavudine?

Stavudine has active ingredients of stavudine. eHealthMe is studying from 10,319 Stavudine users. Check the latest studies of Stavudine.

What is Hypercalcaemia aggravated?

Hypercalcaemia aggravated (elevated calcium (ca+) level in the blood. (norma) is found to be associated with 933 drugs and 343 conditions by eHealthMe. Check the latest studies of Hypercalcaemia aggravated.

On Jul, 07, 2026

10,313 people reported to have side effects when taking Stavudine.
Among them, 19 people (0.18%) have Hypercalcaemia aggravated.

Could Stavudine cause Hypercalcaemia aggravated?

Among these 19 people:

What is the gender of people who have Hypercalcaemia aggravated when taking Stavudine? *

  • female: 42.11 %
  • male: 57.89 %

What is the age of people who have Hypercalcaemia aggravated when taking Stavudine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 12.5 %
  • 30-39: 37.5 %
  • 40-49: 50.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Stavudine? *

  1. Lamivudine: 10 people, 52.63%
  2. Efavirenz: 8 people, 42.11%
  3. Diflucan: 6 people, 31.58%
  4. Alprazolam: 5 people, 26.32%
  5. Sulfamethoxazole: 4 people, 21.05%
  6. Fluconazole: 3 people, 15.79%
  7. Acyclovir: 3 people, 15.79%
  8. Videx: 3 people, 15.79%
  9. Crixivan: 2 people, 10.53%
  10. Atenolol: 2 people, 10.53%

What are other side effects people have besides Hypercalcaemia aggravated? *

  1. Acute Kidney Failure: 8 people, 42.11%
  2. Dehydration (dryness resulting from the removal of water): 7 people, 36.84%
  3. Hypercalciuria (elevated calcium (ca+) level in the urine): 7 people, 36.84%
  4. Immune Reconstitution Syndrome (immune recovery syndrome): 7 people, 36.84%
  5. Weight Decreased: 6 people, 31.58%
  6. Nausea (feeling of having an urge to vomit): 6 people, 31.58%
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 6 people, 31.58%
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 26.32%
  9. Rash Macular (small, flat red spots): 5 people, 26.32%
  10. Hypergammaglobulinaemia (elevated levels of gamma globulin): 5 people, 26.32%

What are the existing conditions these people have? *

  1. Hiv Infection: 8 people, 42.11%

* Approximation only. Some reports may have incomplete information.

Do you take Stavudine and have Hypercalcaemia aggravated?

- Check whether Hypercalcaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stavudine:

Hypercalcaemia aggravated treatments and more:

How severe was Hypercalcaemia aggravated and when was it recovered:

Expand to all the drugs that have ingredients of stavudine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stavudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia aggravated:

Browse all the conditions that are associated with Hypercalcaemia aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on stavudine (the active ingredients of Stavudine) and Stavudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.